Therapeutic Ligands Antagonize Estrogen Receptor Function by Impairing Its Mobility.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
08 08 2019
Historique:
received: 29 08 2018
revised: 28 03 2019
accepted: 17 06 2019
pubmed: 30 7 2019
medline: 10 5 2020
entrez: 30 7 2019
Statut: ppublish

Résumé

Estrogen receptor-positive (ER

Identifiants

pubmed: 31353221
pii: S0092-8674(19)30689-0
doi: 10.1016/j.cell.2019.06.026
pii:
doi:

Substances chimiques

3-(4-(2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid 0
Cinnamates 0
Estrogen Receptor Antagonists 0
Indazoles 0
Ligands 0
Receptors, Estrogen 0
Fulvestrant 22X328QOC4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

949-963.e18

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Jane Guan (J)

Department of Translational Oncology, Genentech, South San Francisco, CA 94080, USA.

Wei Zhou (W)

Department of Translational Oncology, Genentech, South San Francisco, CA 94080, USA.

Marc Hafner (M)

Department of Bioinformatics and Computational Biology, Genentech, South San Francisco, CA 94080, USA.

Robert A Blake (RA)

Department of Biochemical and Cellular Pharmacology, Genentech, South San Francisco, CA 94080, USA.

Cecile Chalouni (C)

Department of Pathology, Genentech, South San Francisco, CA 94080, USA.

Irene P Chen (IP)

Department of Medicine, UCSF, San Francisco, CA 94143, USA.

Tom De Bruyn (T)

Department of Drug Metabolism and Pharmacokinetics, Genentech, South San Francisco, CA 94080, USA.

Jennifer M Giltnane (JM)

Department of Pathology, Genentech, South San Francisco, CA 94080, USA.

Steven J Hartman (SJ)

Theravance Biopharma, South San Francisco, CA 94080, USA.

Amy Heidersbach (A)

Department of Molecular Biology, Genentech, South San Francisco, CA 94080, USA.

Rene Houtman (R)

Department of Research and Development, PamGene, 5211 HH's-Hertogenbosch, the Netherlands.

Ellen Ingalla (E)

Department of Translational Oncology, Genentech, South San Francisco, CA 94080, USA.

Lorn Kategaya (L)

Ideaya Biosciences, South San Francisco, CA 94080, USA.

Tracy Kleinheinz (T)

Department of Biochemical and Cellular Pharmacology, Genentech, South San Francisco, CA 94080, USA.

Jun Li (J)

Department of Discovery Chemistry, Genentech, South San Francisco, CA 94080, USA.

Scott E Martin (SE)

Department of Discovery Oncology, Genentech, South San Francisco, CA 94080, USA.

Zora Modrusan (Z)

Department of Molecular Biology, Genentech, South San Francisco, CA 94080, USA.

Michelle Nannini (M)

Department of Translational Oncology, Genentech, South San Francisco, CA 94080, USA.

Jason Oeh (J)

Department of Translational Oncology, Genentech, South San Francisco, CA 94080, USA.

Savita Ubhayakar (S)

Department of Medicine, UCSF, San Francisco, CA 94143, USA.

Xiaojing Wang (X)

Department of Discovery Chemistry, Genentech, South San Francisco, CA 94080, USA.

Ingrid E Wertz (IE)

Department of Discovery Oncology, Genentech, South San Francisco, CA 94080, USA.

Amy Young (A)

Department of Translational Oncology, Genentech, South San Francisco, CA 94080, USA.

Mamie Yu (M)

Department of Discovery Oncology, Genentech, South San Francisco, CA 94080, USA.

Deepak Sampath (D)

Department of Research, Ultragenyx, Novato, CA 94949, USA.

Jeffrey H Hager (JH)

Ideaya Biosciences, South San Francisco, CA 94080, USA.

Lori S Friedman (LS)

Department of Translational Oncology, Genentech, South San Francisco, CA 94080, USA.

Anneleen Daemen (A)

Department of Bioinformatics and Computational Biology, Genentech, South San Francisco, CA 94080, USA.

Ciara Metcalfe (C)

Department of Translational Oncology, Genentech, South San Francisco, CA 94080, USA. Electronic address: metcalfe.ciara@gene.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH